Temasek, Yunfeng lead $75 mln funding into China genomics firm

SHANGHAI, May 2 (Reuters) - Jack Ma's private equity firm

Yunfeng Capital and Singapore's Temasek have led a $75 million

fund-raising round into genomics company WuXi NextCODE, the firm

said in a statement on Tuesday, underlining a race for medical

data in China.

Read more